Hypoimmune, Allogeneic CD22-Directed CAR T Cells That Evade Innate and Adaptive Immune Rejection for the Treatment of Large B Cell Lymphoma Patients That Are Relapsed/Refractory to CD19-Directed CAR T Cell Therapy
Adam Johnson(Sana Biotechnology (United States)), Terry J. Fry(University of Colorado Anschutz Medical Campus), Andrew McAlister(University of Auckland), Neal Van Hoeven(Sana Biotechnology (United States)), Hallee Wright(Sana Biotechnology (United States)), Trevor J. McGill(Brigham and Women's Hospital), Sundeep Chandra(Sana Biotechnology (United States)), Sonja Schrepfer(Cedars-Sinai Medical Center), Kerrie Enger(Sana Biotechnology (United States)), Chi Young(Sana Biotechnology (United States)), Ouwen Liang(Sana Biotechnology (United States)), Jenny Migliaccio(Sana Biotechnology (United States)), Boris Gorovits(Pfizer (United States)), Prasanna Kumar(St.John's Medical College Hospital), Brian Granger(Sana Biotechnology (United States)), Shannon Joyce(Sana Biotechnology (United States)), Tori Duback(Sana Biotechnology (United States)), Chris Baldeviano(Sana Biotechnology (United States)), Xiaomeng Hu(Huzhou University), Anna Liang(University of Toronto), Sam Crocker(Sana Biotechnology (United States)), Carrie Rocca(Sana Biotechnology (United States)), Vasily V. Vagin(Sana Biotechnology (United States)), Jeremy M. Kinder(Sana Biotechnology (United States))
Cited by 4
Related Papers
A Two-Amino Acid Change in the Hemagglutinin of the 1918 Influenza Virus Abolishes Transmission
|Science|2007|582
Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air
|Proceedings of the National Academy of Sciences|2009|224
Contemporary North American influenza H7 viruses possess human receptor specificity: Implications for virus transmissibility
|Proceedings of the National Academy of Sciences|2008|198
The <i>Mx1</i> Gene Protects Mice against the Pandemic 1918 and Highly Lethal Human H5N1 Influenza Viruses
|Journal of Virology|2007|182